On March 13, 2026, the National Medical Products Administration granted market approval for the world’s first invasive brain-computer interface medical device—the Implantable Brain-Computer Interface Hand Movement Function Compensation System. This cutting-edge system utilizes implantable electrodes to interpret brain signals, empowering paralyzed patients to control limb movements through mere thought. This technological advancement enables patients to perform daily tasks, such as grasping objects and drinking, with greater independence. On March 15, the National Healthcare Security Administration further facilitated its clinical integration by assigning a medical insurance code to the product. This pivotal step not only bridges the gap between market authorization and real-world clinical use but also signifies the brain-computer interface industry's formal entry into the commercial application phase.